Back to search

Article

WASF2 Overexpression and Promoter Hypomethylation Are Associated With Poor Clinical Outcomes in Hepatocellular Carcinoma

2021-11-12

Abstract excerpt

<title>Abstract</title> <p><bold>Background:</bold> Hepatocellular carcinoma (HCC) is one of the most common and lethal cancers worldwide. Wiskott-Aldrich syndrome protein family member 2 (WASF2) is an integral member of the actin cytoskeleton pathway that plays a crucial role in cell motility. In this study, we aimed to explore the role of WASF2 in HCC carcinogenesis and its regulatory mechanism. <bold>Methods:<...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
0eb0f583-5ad1-5a38-8ca6-3623b244777f
DOI
10.21203/rs.3.rs-1065747/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
WASF2 Overexpression and Promoter Hypomethylation Are Associated With Poor Clinical Outcomes in Hepatocellular CarcinomaDOI 10.21203/rs.3.rs-1065747/v1
Select a neighboring publication to make it the new centre.